Debiopharm Group, a leader in the field of drug development and innovative drug delivery processes, has decided to use an AlpVision digital solution for product authentication. This strategic decision will involve the setup and implementation of a tool to protect against potential pharmaceutical product counterfeiters at a worldwide level.
“Even though Debiopharm is not aware of any existing counterfeits of its manufactured products, our group will implement such tools during 2011. This will constitute an additional measure proposed by Debiopharm in the interest of our partners and of patients’ security,” said a spokesman at Debiopharm.
“Counterfeiting is an unacceptable threat for healthcare. Debiopharm wants to further protect its products with appropriate systems. Drugs manufactured by Debiopharm are safe and under control; it is our aim to make our best efforts to guarantee this safety,” he continued.
AlpVision is very proud to see its digital solutions for product authentication adopted by such an important pharma industry player as Debiopharm, a recipient of the ‘2010 Frost & Sullivan European Biopharmaceuticals Company of the Year’ award.